Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
- Resource Type
- Article
- Authors
- Yousuf, Ahmed J; Mohammed, Seid; Carr, Liesl; Yavari Ramsheh, Mohammadali; Micieli, Claudia; Mistry, Vijay; Haldar, Kairobi; Wright, Adam; Novotny, Petr; Parker, Sarah; Glover, Sarah; Finch, Joanne; Quann, Niamh; Brookes, Cassandra L; Hobson, Rachel; Ibrahim, Wadah; Russell, Richard J; John, Catherine; Grimbaldeston, Michele A; Choy, David F; Cheung, Dorothy; Steiner, Michael; Greening, Neil J; Brightling, Christopher E
- Source
- In The Lancet Respiratory Medicine May 2022 10(5):469-477
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600